3 Biotech Stocks That Could Soar This Week
The biopharmaceutical industry's summer doldrums will unofficially come to a close this week thanks to steady gusts of wind from the Food and Drug Administration, plus a slate of presentations in front of scientists and investors.
Some events are more important than others. If you only have time to focus on a few of the stories about to unfold this week, make sure you don't miss upcoming catalysts for Alnylam (NASDAQ: ALNY), Moderna (NASDAQ: MRNA), and Aimmune Therapeutics (NASDAQ: AIMT). Here's what to look out for.
Image source: Getty Images.
Source Fool.com


